Your browser doesn't support javascript.
loading
Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study.
Østergaard, Helena Bleken; Humphreys, Valerie; Hengeveld, Ellen Margo; Honoré, Julie Broe; Mach, François; Visseren, Frank L J; Westerink, Jan; Yadav, Gourav; Mosenzon, Ofri.
Afiliação
  • Østergaard HB; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Humphreys V; Dublin, Ireland, Diabetes Ireland Advocacy Group.
  • Hengeveld EM; Novo Nordisk A/S, Søborg, Denmark.
  • Honoré JB; Novo Nordisk A/S, Søborg, Denmark.
  • Mach F; Cardiology Division, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Visseren FLJ; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Westerink J; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Yadav G; Novo Nordisk Global Business Services, Bengaluru, India.
  • Mosenzon O; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Diabetes Obes Metab ; 25(2): 435-443, 2023 02.
Article em En | MEDLINE | ID: mdl-36199242

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article